Cardinal, McKesson Incentives Are At Center Of Bristol Restatement

Bristol's revised approach to accounting for excess inventory leaves the company room to offer trade incentives in the future

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet